Cargando…
Paraoxonase 1 Activity is Associated with Interleukin-6 Levels in Type 2 Diabetes: Effects of Age and Gender
BACKGROUND: A further understanding of the mechanisms linking inflammation to T2D and related complications can help prevent or control this silent but dangerous disease. This study was conducted to determine the association between paraoxonase 1 (PON1) activity and interleukin-6 (IL-6) in type 2 di...
Autores principales: | Nikzad, Armin, Alizadeh, Ahad, Abediankenari, Saeid, Kashi, Zahra, Mahrooz, Abdolkarim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080564/ https://www.ncbi.nlm.nih.gov/pubmed/37033289 http://dx.doi.org/10.4103/ijpvm.ijpvm_161_21 |
Ejemplares similares
-
The Role of Metformin Response in Lipid Metabolism in Patients with Recent-Onset Type 2 Diabetes: HbA1c Level as a Criterion for Designating Patients as Responders or Nonresponders to Metformin
por: Kashi, Zahra, et al.
Publicado: (2016) -
Paraoxonase-2 variants potentially influence insulin resistance, beta-cell function, and their interrelationships with alanine aminotransferase in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018) -
Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes
por: Qujeq, Durdi, et al.
Publicado: (2018) -
Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients
por: Shokri, Fazlollah, et al.
Publicado: (2016) -
The Atherogenic Index Log (Triglyceride/HDL-Cholesterol) as a Biomarker to Identify Type 2 Diabetes Patients with Poor Glycemic Control
por: Nosrati, Mani, et al.
Publicado: (2021)